Domagk Smith Laboratories Profile
Key Indicators
- Authorised Capital ₹ 0.70 M
- Paid Up Capital ₹ 0.10 M
- Company Age 24 Year, 30 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.52 M
- Revenue Growth 15.13%
- Profit Growth 19.13%
- Ebitda 28.62%
- Net Worth 22.81%
- Total Assets 4.43%
About Domagk Smith Laboratories
Domagk Smith Laboratories Private Limited (DSLPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 25 January 2001 and has a history of 24 years. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.70 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹4.52 M.
Sunil Batra, Deepak Satija, Rajesh Goyal, and Two other members serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74899DL2001PTC109384
- Company No.
109384
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Jan 2001
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
What products or services does Domagk Smith Laboratories Private Limited offer?
Domagk Smith Laboratories Private Limited offers a wide range of products and services, including Common Disease Medicines, Pharmaceutical Tablets, Pain Relief Drugs & Pharmaceuticals, Diclofenac, Arthritic Drugs, Antipyretic Medication, Paracetamol Tablets, Antibacterial Drugs, Ofloxacin Tablet IP, Pharma Franchise.
Who are the key members and board of directors at Domagk Smith Laboratories?
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sunil Batra  | Director | 25-Jan-2001 | Current |
| Deepak Satija | Director | 25-Jan-2001 | Current |
| Rajesh Goyal | Director | 25-Jan-2001 | Current |
| Daya Goyal | Director | 01-Oct-2006 | Current |
| Reena Satija | Director | 01-Oct-2006 | Current |
Financial Performance of Domagk Smith Laboratories.
Domagk Smith Laboratories Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 15.13% increase. The company also saw a substantial improvement in profitability, with a 19.13% increase in profit. The company's net worth Soared by an impressive increase of 22.81%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Domagk Smith Laboratories?
In 2023, Domagk Smith Laboratories had a public holding of 1.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹4.52 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.45 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Aug 2023 | Hdfc Bank Limited | ₹1.52 M | Open |
| 06 Oct 2022 | Hdfc Bank Limited | ₹1.50 M | Open |
| 10 Sep 2021 | Hdfc Bank Limited | ₹1.50 M | Open |
How Many Employees Work at Domagk Smith Laboratories?
Domagk Smith Laboratories has a workforce of 23 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Domagk Smith Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Domagk Smith Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.